The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Overexpression of 11β-Hydroxysteroid Dehydrogenase-1 in Adipose Tissue Is Associated with Acquired Obesity and Features of Insulin Resistance: Studies in Young Adult Monozygotic Twins
Abstract
11beta-Hydroxysteroid dehydrogenase type 1 (11beta-HSD-1) catalyzes the interconversion of inactive cortisone to active cortisol. Overexpression of 11beta-HSD-1 in murine adipose tissue results in glucocorticoid receptor (GR)alpha overexpression, central obesity, and insulin resistance. It is controversial whether 11beta-HSD-1 or GRalpha expression are increased in human adipose tissue in obesity. We studied effects of acquired obesity on 11beta-HSD-1 gene (real-time PCR) and protein (Western blotting) expression in sc adipose tissue in 17 monozygotic twin pairs aged 24-27 yr with a mean intrapair difference in body mass index (BMI) of 3.8 kg/m(2) (range 0.4-10.1 kg/m(2)). Intrapair correlations were calculated to study effects of acquired obesity on 11beta-HSD-1 expression. Western blot analysis of adipose tissue homogenates identified approximately 50- and approximately 68-kDa proteins specific for 11beta-HSD-1. Both structural forms correlated positively with 11beta-HSD-1 mRNA concentrations. Intrapair differences in 11beta-HSD-1 mRNA, and the 50- and 68-kDa proteins in sc adipose tissue correlated positively with those in BMI (kilograms per square meter) (r = 0.78 for 11beta-HSD-1 mRNA, P = 0.0002; r = 0.87 for the 11beta-HSD-1 50-kDa protein, P = 0.0003; and r = 0.62 for the 11beta-HSD-1 68-kDa protein, P = 0.033), total body fat (percent) (r = 0.65, P = 0.005; r = 0.83, P = 0.001; and r = 0.69, P = 0.013, respectively) and sc fat (cubed centimeters) (r = 0.66, P = 0.004; r = 0.94, P = 0.0001; and r = 0.71, P = 0.009, respectively). Furthermore, 11beta-HSD-1 mRNA and 50-kDa protein expression, but not 68-kDa protein expression, correlated positively with intrapair differences in intraabdominal fat mass (cubed centimeters) (r = 0.62, P = 0.008; r = 0.69, P = 0.013; r = 0.48, P = 0.112) and serum fasting insulin concentration (milliunits per liter) (r = 0.76, P = 0.0004; r = 0.60, P = 0.037; and r = 0.43, P = 0.160, respectively). Intrapair differences in GRalpha expression were significantly inversely correlated with those in BMI and total and sc fat mass. In conclusion, expression of 11beta-HSD-1 in sc adipose tissue is increased in human acquired obesity and is closely related to accumulation of sc and intraabdominal fat and features of insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These include increased production of inflammatory cytokines, 35,36 plasminogen activator inhibitor-1, 37 and other bioactive products 38 -40 ; at the same time the potentially protective adipokine, adiponectin, is reduced.41,42”
From Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement (2005) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,218
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766
Mazess, R., Barden, H. S., Bisek, J., & Hanson, J. (1990) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/51.6.1106 · Cited by 1,465
Desbuquois, B., & Aurbach, G. D. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-5-732 · Cited by 1,295
Classical twin studies and beyond
Boomsma, D., Busjahn, A., & Peltonen, L. (2002) · Nature Reviews Genetics · doi:10.1038/nrg932 · Cited by 1,105
Kotelevtsev, Y. V., Holmes, M. C., Burchell, A. N., Houston, P., Schmoll, D., Jamieson, P. M., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 863
Vidal‐Puig, A., Considine, R. V., Jimenez‐Liñan, M., Werman, A., Pories, W. J., Caro, J. F., & Flier, J. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119424 · Cited by 785
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753
Cited by
Sorted by citations
Items 101–200 of 215
Hale, C., Véniant, M. M., Wang, Z., Chen, M., McCormick, J., Cupples, R. L., Hickman, D., Min, X., Sudom, A. M., Xu, H., et al. (2007) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2007.00603.x · Cited by 34
Vogel, H., Scherneck, S., Kanzleiter, T., Benz, V., Kluge, R., Stadion, M., Kryvych, S., Blüher, M., Klöting, N., Joost, H., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds213 · Cited by 33
Rosiglitazone decreases 11β‐hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue
Mai, K., Andres, J., Bobbert, T., Maser‐Gluth, C., Möhlig, M., Bähr, V., Pfeiffer, A. F. H., Spranger, J., & Diederich, S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02903.x · Cited by 33
Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 in Obesity
Wake, D. J., & Walker, B. R. (2006) · Endocrine · doi:10.1385/endo:29:1:101 · Cited by 32
Torrecilla, E., Fernández‐Vázquez, G., Vicent, D., Sánchez‐Franco, F., Barabash, A., Cabrerizo, L., Sánchez-Pernaute, A., Torres, A. J., & Rubio, M. Á. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0524-9 · Cited by 31
Minichino, A., Ando, A. M. C., Francesconi, M., Salatino, A., Chiaie, R. D., & Cadenhead, K. S. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.03.020 · Cited by 32
Svendsen, P. F., Madsbad, S., Nilas, L., Paulsen, S. K., & Pedersen, S. B. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.165 · Cited by 31
Li, X., Lindquist, S., Chen, R., Myrnäs, T., Angsten, G., Olsson, T., & Hernell, O. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803470 · Cited by 31
Pharmacological Targeting of Adipocytes/Fat Metabolism for Treatment of Obesity and Diabetes
Pilch, P. F., & Bergenhem, N. C. H. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026104 · Cited by 31
Fotsch, C. H., Bartberger, M. D., Bercot, E. A., Chen, M., Cupples, R. L., Emery, M., Fretland, J., Guram, A. S., Hale, C., Han, N., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801073z · Cited by 29
Effects of Acquired Obesity on Endothelial Function in Monozygotic Twins
Pietiläinen, K. H., Bergholm, R., Rissanen, A., Kaprio, J. A., Häkkinen, A., Sattar, N. A., & Yki‐Järvinen, H. (2006) · Obesity · doi:10.1038/oby.2006.96 · Cited by 28
Self-citationTime of the day for 11β‐HSD1 inhibition plays a role in improving glucose homeostasis in DIO mice
Véniant, M. M., Hale, C., Komorowski, R., Chen, M. M., Jean, D. J. S., Fotsch, C. H., & Wang, M. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00911.x · Cited by 29
Šimonytė, K., Rask, E., Näslund, I., Angelhed, J., Lönn, L., Olsson, T., & Mattsson, C. (2009) · Obesity · doi:10.1038/oby.2009.99 · Cited by 28
Vihma, V., Naukkarinen, J., Turpeinen, U., Hämäläinen, E., Kaprio, J., Rissanen, A., Heinonen, S., Hakkarainen, A., Lundbom, J., Lundbom, N., et al. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.06.007 · Cited by 27
Self-citationLiu, J., Wang, L., Zhang, A., Di, W., Zhang, X., Wu, L., Yu, J., Zha, J., Lv, S., Cheng, P., et al. (2011) · Endocrine Journal · doi:10.1507/endocrj.k10e-318 · Cited by 27
Vítků, J., Stárka, L., Bičı́ková, M., Hill, M., Heráček, J., Kolátorová, L., & Hampl, R. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.07.007 · Cited by 27
van Dongen, J., Willemsen, G. A. H. M., Heijmans, B. T., Neuteboom, J., Kluft, C., Jansen, R., Penninx, B. W. J. H., Slagboom, P. E., de Geus, E. J. C., & Boomsma, D. I. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.24 · Cited by 26
Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors
McMinn, D. L., Rew, Y., Sudom, A. M., Caille, S., DeGraffenreid, M. R., He, X., Hungate, R. W., Jiang, B., Jaén, J. C., Julian, L. D., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.026 · Cited by 24
Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 in Antidiabetic Therapy
Wang, M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_6 · Cited by 24
Chiodini, I., Gaudio, A., Eller-Vainicher, C., Morelli, V., Aresta, C., Zhukouskaya, V. V., Merlotti, D., Orsi, E., Barbieri, A. M., Fustinoni, S., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00037 · Cited by 23
Tagawa, N., Minamitani, E., Yamaguchi, Y., & Kobayashi, Y. (2011) · Steroids · doi:10.1016/j.steroids.2011.09.005 · Cited by 22
Mifepristone Improves Adipose Tissue Insulin Sensitivity in Insulin Resistant Individuals
Gubbi, S., Muniyappa, R., Sharma, S. T., Grewal, S., McGlotten, R., & Nieman, L. K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab046 · Cited by 23
Sukhija, R., Kakar, P., Mehta, V., & Mehta, J. L. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.03.028 · Cited by 23
Koška, J., de Courten, B. V., Wake, D. J., Nair, S., Walker, B. R., Bunt, J. C., Permana, P. A., Lindsay, R. S., & Tataranni, P. A. (2006) · Obesity · doi:10.1038/oby.2006.175 · Cited by 23
Michailidou, Z., Coll, A. P., Kenyon, C. J., Morton, N. M., O’Rahilly, S., Seckl, J. R., & Chapman, K. E. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0090 · Cited by 21
Methlie, P., Dankel, S. N., Myhra, T. S., Christensen, B. J., Gjerde, J., Fadnes, D. J., Våge, V., Løvås, K., & Mellgren, G. (2013) · Obesity · doi:10.1002/oby.20449 · Cited by 21
Honda, Y., Ohno, S., & Nakajin, S. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.07.003 · Cited by 21
Gutierrez-Mariscal, F. M., Yubero‐Serrano, E. M., Rangel-Zúñiga, O. A., Marı́n, C., García‐Ríos, A., Pérez‐Martínez, P., Delgado‐Lista, J., Malagón, M. M., Tinahones, F. J., Pérez‐Jiménez, F., et al. (2013) · The Journals of Gerontology Series A · doi:10.1093/gerona/glt174 · Cited by 21
Is metabolic syndrome a mild form of Cushing’s syndrome?
Krikorian, A., & Khan, M. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9142-4 · Cited by 20
Morelli, V., Aresta, C., Gaudio, A., Eller-Vainicher, C., Zhukouskaya, V. V., Merlotti, D., Orsi, E., Barbieri, A. M., Fustinoni, S., Polledri, E., et al. (2020) · Endocrine · doi:10.1007/s12020-020-02212-9 · Cited by 20
Mlinar, B., Marc, J., Jensterle, M., Bokal, E. V., Jerin, A., & Pfeifer, M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.12.002 · Cited by 20
Sex Differences in Body Fat Distribution
Veilleux, A., & Tchernof, A. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0965-6_5 · Cited by 17
Resveratrol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes
Tagawa, N., Kubota, S., Kato, I., & Kobayashi, Y. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0066 · Cited by 18
Jewell, C. M., Katen, K. S., Barber, L. M., Cannon, C., Garantziotis, S., & Cidlowski, J. A. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00105.2016 · Cited by 17
Grino, M. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00542.2005 · Cited by 17
2 Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1
Su, X., Vicker, N., & Potter, B. V. L. (2008) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(07)00002-1 · Cited by 17
Sex Differences in Body Fat Distribution
Mansour, M. F., Chan, C.-W. J., Laforest, S., Veilleux, A., & Tchernof, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-52031-5_8 · Cited by 17
Winnick, J. J., Ramnanan, C. J., Saraswathi, V., Roop, J., Scott, M., Jacobson, P. B., Jung, P. M., Basu, R., Cherrington, A. D., & Edgerton, D. S. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00639.2012 · Cited by 15
Tous les acides gras saturés ont-ils le même effet métabolique ?
Walrand, S., Fisch, F., & Bourre, J. M. (2010) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2010.02.003 · Cited by 18
Dujić, T., Bego, T., Mlinar, B., Semiz, S., Malenica, M., Prnjavorac, B., Ostanek, B., Marc, J., & Čaušević, A. (2012) · Biochemia Medica · doi:10.11613/bm.2012.008 · Cited by 16
Su, X., Pradaux, F., THOMAS, M. P., Szeto, M. W. Y., Halem, H. A., Culler, M. D., Vicker, N., & Potter, B. V. L. (2010) · ChemMedChem · doi:10.1002/cmdc.201000081 · Cited by 15
Venier, O., Pascal, C., Braun, A., Namane, C., Mougenot, P., Crespin, O., Pacquet, F., Mougenot, C., Monseau, C., Onofri, B., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.02.111 · Cited by 14
Goedecke, J. H., Chorell, E., Livingstone, D. E. W., Stimson, R. H., Hayes, P. M., Adams, K. S., Dave, J. A., Victor, H., Levitt, N. S., Kahn, S. E., et al. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.94 · Cited by 14
Sex‐specific Difference in the Interconversion of Cortisol and Cortisone in Men and Women
Vierhapper, H., Heinze, G., & Nowotny, P. (2007) · Obesity · doi:10.1038/oby.2007.592 · Cited by 14
Dineen, R., Martin‐Grace, J., Ahmed, K. M. S., TAYLOR, A. E. R., Shaheen, F., Schiffer, L., Gilligan, L. C., Lavery, G. G., Frizelle, I. M., Gunness, A., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad370 · Cited by 14
Venier, O., Pascal, C., Braun, A., Namane, C., Mougenot, P., Crespin, O., Pacquet, F., Mougenot, C., Monseau, C., Onofri, B., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.02.018 · Cited by 13
Adipose targets for obesity drug development
Boss, O., & Bergenhem, N. C. H. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.1.119 · Cited by 12
Fasting plasma total ghrelin concentrations in monozygotic twins discordant for obesity
Leskelä, P., Ukkola, O. H., Vartiainen, J., Rönnemaa, T., Kaprio, J. A., Bouchard, C., & Kesäniemi, Y. A. (2009) · Metabolism · doi:10.1016/j.metabol.2008.09.010 · Cited by 12
Self-citationMechanisms of androgenic action in adipose tissue
Veilleux, A., & Blouin, K. (2009) · Clinical Lipidology · doi:10.2217/clp.09.16 · Cited by 10
Synthesis of hupehenols A, B, and E from protopanaxadiol
Shao, L., Xu, J. J., Li, X., Zhang, Z., Shi, X., Ren, J. X., He, J., Zhao, Y., Leng, Y., Xia, C., et al. (2016) · RSC Advances · doi:10.1039/c6ra04236h · Cited by 11
Park, S. B., Park, J. S., Jung, W. H., Park, A., Jo, S. R., Kim, H. Y., Rhee, S. D., Ryu, S. Y., Jeong, H. G., Park, S., et al. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.014 · Cited by 10
Cheng, Y., Wang, L., Iacono, L. C., Zhang, D., Chen, W., Gong, J., Humphreys, W. G., & Gan, J. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13421 · Cited by 10
Type 2 diabetes: Gaining insight into the disease process using proteomics
Maris, M., Overbergh, L., & Mathieu, C. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780093 · Cited by 9
The Expression of Omental 11β-HSD1 Is Not Increased in Severely Obese Women with Metabolic Syndrome
Michalaki, M. A., Kyriazopoulou, V. E., Antonacopoulou, A. G., Koika, V., Nikolaou, M., Tsoukas, A. S., Kalfarentzos, F. E., Vagenakis, A. G., Voukelatou, G., & Papavassiliou, A. G. (2012) · Obesity Facts · doi:10.1159/000336755 · Cited by 9
Akyürek, N., Atabek, M. E., Eklioğlu, B. S., & Alp, H. (2014) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0253 · Cited by 9
Deng, X., Huang, S., Ren, J. X., Pan, Z., Shen, Y., Zhou, H., Zuo, Z., Leng, Y., & Zhao, Q. (2022) · Natural Products and Bioprospecting · doi:10.1007/s13659-022-00358-9 · Cited by 9
Su, X., Vicker, N., THOMAS, M. P., Pradaux, F., Halem, H. A., Culler, M. D., & Potter, B. V. L. (2011) · ChemMedChem · doi:10.1002/cmdc.201100144 · Cited by 9
Kiyonaga, D., Tagawa, N., Yamaguchi, Y., Wakabayashi, M., Kogure, T., Ueda, M., Miyata, O., & Kobayashi, Y. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00072 · Cited by 9
Karlsson, C., Jernås, M., Olsson, B., Lystig, T., Gummesson, A., Storlien, L. H., Groop, L., & Carlsson, B. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.03.009 · Cited by 8
Tissue‐specific glucocorticoid excess in the metabolic syndrome: 11β‐HSD1 as a therapeutic target
Wang, M. (2006) · Drug Development Research · doi:10.1002/ddr.20123 · Cited by 8
Meas, T., Carreira, E., Wang, Y., Rauh, M., Poitou, C., Clément, K., Dötsch, J., & Lévy‐Marchal, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0254 · Cited by 8
Increased Aldosterone: Mechanism of Hypertension in Obesity
Flynn, C. A. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.04.009 · Cited by 8
CRISPR-mediated gene editing to rescue haploinsufficient obesity syndrome
Wang, Z., Liu, Y., Qu, S., & Zhang, C. (2019) · Protein & Cell · doi:10.1007/s13238-019-0635-y · Cited by 6
Moon, S., Lee, Y., Kim, J., & Lee, I. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.12.020 · Cited by 7
Reduced Levels of Circulating 7α-Hydroxy-Dehydroepiandrosterone in Treated Adolescent Obese Patients
Máčová, L., Bičı́ková, M., Zamrazilová, H., Hill, M., Kazihnítková, H., Sedláčková, B., & Stárka, L. (2014) · Physiological Research · doi:10.33549/physiolres.932540 · Cited by 6
Brix, J. M., Tura, A., Herz, C. T., Feder, A., Krzizek, E.-C., Parzer, V., Pacini, G., & Ludvik, B. H. (2021) · Obesity Facts · doi:10.1159/000517766 · Cited by 6
Fichna, M., Żurawek, M., Gryczyńska, M., Sowińska, A., Nowak, J., & Ruchała, M. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.03.027 · Cited by 6
Lipotoxicité et insulinorésistance
Magnan, C. (2006) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2006.04.006 · Cited by 6
Mondok, Á., Varga, I., Gláz, E., Szücs, N., Tóth, M., Patócs, A., Bekő, G., & Rácz, K. (2009) · Steroids · doi:10.1016/j.steroids.2009.03.003 · Cited by 5
Miceli, D. D., Abiuso, A. M. B., Vidal, P. N., Gallelli, M. F., Pignataro, O. P., & Castillo, V. A. (2018) · Open Veterinary Journal · doi:10.4314/ovj.v8i1.13 · Cited by 4
Steroid Hormones Related to 11β-hydroxysteroid Dehydrogenase Type 1 in Treated Obesity
Máčová, L., SOSVOROVÁ, L., Vítků, J., Bičı́ková, M., Hill, M., Zamrazilová, H., Sedláčková, B., & Stárka, L. (2015) · Physiological Research · doi:10.33549/physiolres.933073 · Cited by 4
Ton, H. P. Y. S. H. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000522 · Cited by 4
Torres, A., Íñiguez, G., Ferrario, M., & Verónica Mericq, G. (2012) · ISRN Endocrinology · doi:10.5402/2012/787201 · Cited by 3
Cell-type specific regulation of the human 11beta-hydroxysteroid dehydrogenase type 1 promoter
Andres, J., Mai, K., Möhlig, M., Weickert, M. O., Bumke‐Vogt, C., Diederich, S., Pfeiffer, A. F. H., Bähr, V., & Spranger, J. (2007) · Archives of Physiology and Biochemistry · doi:10.1080/13813450701531219 · Cited by 3
Specific Advantages of Twin Registries and Biobanks
Kaprio, J. A. (2010) · Methods in molecular biology · doi:10.1007/978-1-59745-423-0_9 · Cited by 2
Self-citationGlucocorticoid antagonists and 11β-HSD1 inhibitors
Wang, M. (2007) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2007.10.001 · Cited by 2
Lipson, V. V., Shirobokova, M. G., & Petrova, O. N. (2013) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-013-0900-y · Cited by 2
Diazepane–acetamide derivatives as selective 11β-hydroxysteroid dehydrogenase type 1 inhibitors
Odermatt, A. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770902911490 · Cited by 2
Klusoňová, P., Pátková, L., Ergang, P., Mikšı́k, I., Zicha, J., Kuneš, J., & Pácha, J. (2011) · Steroids · doi:10.1016/j.steroids.2011.06.003 · Cited by 2
Cortisol Metabolism as a Regulator of the Tissue-Specific Glucocorticoid Action
Sbardella, E., & Tomlinson, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_14 · Cited by 2
El síndrome metabólico como síndrome de Cushing intrahepatocitario
Vázquez, G. F., Torrecilla, E., & Rubio, M. Á. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.12.003 · Cited by 2
Structure-Based and Property-Compliant Library Design of 11β-HSD1 Adamantyl Amide Inhibitors
Paderes, G. D., Dress, K. R., Huang, B., Elleraas, J., Rejto, P. A., & Pauly, T. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-931-4_10 · Cited by 1
Corticosteroid Receptors, Their Chaperones and Cochaperones: How Do They Modulate Adipogenesis?
Toneatto, J., Charó, N. L., Naselli, A., Muñoz-Bernart, M., Lombardi, A., & Piwien‐Pilipuk, G. (2014) · Nuclear Receptor Research · doi:10.11131/2014/101092 · Cited by 1
11β-Hydroxysteroid Dehydrogenase Type 1 and Obesity
Stimson, R. H., & Walker, B. R. (2007) · Humana Press eBooks · doi:10.1007/978-1-60327-139-4_10 · Cited by 1
Estrogen and Glucocorticoid Metabolism
Andersson, T. (2010) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Inflammation and end-organ damage with obesity and gender
Bloor, I. D. (2012) · Nottingham ePrints (University of Nottingham)
Adipose tissue inflammation, liver fat and insulin resistance in humans
Makkonen, J. (2010) · Työväentutkimus Vuosikirja
Smith, C. S., Spertus, J. A., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Grundy, S. M., Cleeman, J. I., Daniels, S. R., & Donato, K. A. (2006)
The metabolic syndrome as intrahepatocytic Cushing's syndrome
Vázquez, G. F., Torrecilla, E., & Rubio, M. Á. (2011) · Endocrinología y Nutrición (English Edition) · doi:10.1016/s2173-5093(11)70039-3
Clinical syndromes of glucocorticoid resistance and hypersensitivity
Malchoff, C. D., & Malchoff, D. M. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000224803.24071.0b
Glucocorticoids as Modulators of Adipose Inflammation
Morton, N. M. (2009) · Oxidative stress and disease · doi:10.1201/9781420091311.ch8
Denton, N. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198865278.003.0007
(2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282c3a898
(2011) · CRC Press eBooks · doi:10.1201/b10790-15
Alterations in peripheral glucocorticoid metabolism : effects of weight changes
Šimonytė, K. (2011) · DiVA at Umeå University (Umeå University)
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000202323.44809.4f
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000224813.85060.ab
Metadata
- Authors
- Kannisto, K., Pietiläinen, K. H., Ehrenborg, E., Rissanen, A., Kaprio, J., Hamsten, A., & Yki-Järvinen, H.
- Affiliations
- Karolinska Institutet (SE)
- University of Helsinki (FI)
- Helsinki University Hospital (FI)
- Corresponding author
- Kannisto, Katja
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-09
- Volume
- 89
- Issue
- 9
- Pages
- 4414-4421
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2102335700
- Cited by
- 205
- References
- 45
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 6 · 2016: 5 · 2015: 8 · 2014: 11 · 2013: 10 · 2012: 10
- FWCI
- 17.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Helsingin ja Uudenmaan Sairaanhoitopiiri
- European Commission (QLG2-CT-2002-01254, 01254)
- Hjärt-Lungfonden
- Karolinska Institutet
- Stockholms Läns Landsting
- Svenska Läkaresällskapet
- Medical Research Council
- Socialstyrelsen
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, insulin resistance, subcutaneous adipose tissue, monozygotic twins, glucocorticoid receptor alpha, cortisol, body mass index, adipose tissue gene expression, young adults, adipocyte hypertrophy
- MeSH terms
- Adipose Tissue, Fatty Acids, Nonesterified, Humans, Insulin Resistance, Obesity, Receptors, Glucocorticoid, RNA, Messenger, Twins, Monozygotic, Up-Regulation, Gene Expression Regulation, Enzymologic, 11-beta-Hydroxysteroid Dehydrogenase Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
